ClinicalTrials.gg

Program

AK139

A development code.

Its studies are mostly in Prurigo · Chronic Urticaria · Nasal Polyps · Dermatitis, Atopic · Rhinitis, Allergic, Seasonal, led by Akeso.

Furthest: phase 2, since Feb 3, 20266 company-led studies, 6 open or runningNext primary completion: Dec 27, 2026 (phase 2)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Akeso66 open or runningphase 2since Feb 3, 2026Feb 3, 2026Dec 27, 2026phase 2 · NCT07436221

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Feb 3, 2026First studies: 2 phase 2 studiesFirst studyNCT07436234, NCT07436221
  2. Mar 25, 2026Phase 2 study in Moderate-to-Severe Atopic DermatitisNCT07502222 · 168 planned
  3. Aug 5, 2026Phase 2 study in Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)NCT07755371 · 75 planned · China
  4. Sep 24, 2026Phase 2 study in Chronic UrticariaNCT07875426 · 201 planned
  5. Oct 8, 2026Phase 2 study in Prurigo Nodularis (PN)NCT07883213 · 132 planned

Ahead

  1. Dec 27, 2026Primary completion: phase 2 study in AsthmaNCT07436221
  2. Apr 30, 2027Primary completion: phase 2 study in Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)NCT07755371
  3. Aug 2027Primary completion: phase 2 study in Prurigo Nodularis (PN)NCT07883213
  4. Nov 2027Primary completion: phase 2 study in Moderate-to-Severe Atopic DermatitisNCT07502222

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 6 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07883213Prurigo Nodularis (PN)2Not yet recruitingAug 2027132
NCT07875426Chronic Urticaria2Not yet recruitingJan 8, 2029201
NCT07755371Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) · China2Not yet recruitingApr 30, 202775
NCT07502222Moderate-to-Severe Atopic Dermatitis2Not yet recruitingNov 2027168
NCT07436234Rhinitis, Allergic, Seasonal · China2Not yet recruitingSep 30, 2026111
NCT07436221Asthma · China2Not yet recruitingDec 27, 2026160

How it is read

Names in the registry

  • “AK139”, 11 entries

Codes read as this program: AK139.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.